Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
KROS
PROF
Add up to 3 more stocks
KROS
Keros Therapeutics, Inc.
-2.17%
$11.27-0.25Delayed quote: Oct 6, 2026, 1:04 PM EDT
Market Cap
$223.45M
52W Range
$9.69 - $22.55
PROF
Profound Medical Corp.
+2.64%
$6.19+0.16Delayed quote: Oct 6, 2026, 1:04 PM EDT
Market Cap
$224.89M
52W Range
$4.80 - $8.95
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 0.85 | 4.52 |
| P/S Ratio | 14.88 | 11.83 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 94.7% | 71.8% |
| Operating Margin | 28.9% | -256.3% |
| Net Margin | -553.9% | -171.7% |
| ROE | -31.7% | -65.6% |
| ROA | -28.9% | -52.3% |
| ROIC | -36.5% | -61.0% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 21.96 | 6.45 |
| Quick Ratio | 21.96 | 5.31 |
| Debt/Equity | 0.06 | 0.15 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.